Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk

References

• Ter Horst R, van den Munckhof ICL, Schraa K, et al. Sex-specific regulation of inflammation and metabolic syndrome in obesity. Arterioscler Thromb Vasc Biol. 2020;Atvbaha–120.
   Google Scholar
• Fortes MSR, Rosa SED, Coutinho W, Neves EB. Epidemiological study of metabolic syndrome in Brazilian soldiers. Arch Endocrinol Metabol. 2019;63(4):345–350. doi:10.20945/2359-3997000000115
   PubMedGoogle Scholar
• Kim LJ, Polotsky VY. Carotid body and metabolic syndrome: mechanisms and potential therapeutic targets. Int J Mol Sci. 2020;21(14):5117. doi:10.3390/ijms21145117
   PubMedGoogle Scholar
• Hamjane N, Benyahya F, Nourouti NG, Mechita MB, Barakat A. Cardiovascular diseases and metabolic abnormalities associated with obesity: what is the role of inflammatory responses? A systematic review. Microvasc Res. 2020;131:104023. doi:10.1016/j.mvr.2020.104023
   PubMed Web of Science ®Google Scholar
• Carioca AAF, Gorgulho B, de Mello Fontanelli M, Fisberg RM, Marchioni DM. Cardiometabolic risk profile and diet quality among internal migrants in Brazil: a population-based study. Eur J Nutr. 2020. doi:10.1007/s00394-020-02281-6
   Google Scholar
• Higuita-Gutiérrez LF, Martínez Quiroz WJ, Cardona-Arias JA. Prevalence of metabolic syndrome and its association with sociodemographic characteristics in participants of a public chronic disease control program in Medellin, Colombia, in 2018. Diabetes Metab Syndr Obes. 2020;13:1161–1169. doi:10.2147/DMSO.S242826
   PubMedGoogle Scholar
• Lorcerie B, Audia S, Samson M, et al. Diagnosis of hyperferritinemia in routine clinical practice. Presse medicale. 2017;46(12 Pt 2):e329–e338. doi:10.1016/j.lpm.2017.09.028
   PubMedGoogle Scholar
• Cadenas B, Fita-Torró J, Bermúdez-Cortés M, et al. L-Ferritin: one gene, five diseases; from hereditary hyperferritinemia to hypoferritinemia-report of new cases. Pharmaceuticals. 2019;12(1):17.
   Google Scholar
• Kurz K, Lanser L, Seifert M, Kocher F, Pölzl G, Weiss G. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure. ESC Heart Fail. 2020;7(4):1880–1890. doi:10.1002/ehf2.12755
   PubMedGoogle Scholar
• Rametta R, Fracanzani AL, Fargion S, Dongiovanni P. Dysmetabolic hyperferritinemia and dysmetabolic iron overload syndrome (DIOS): two related conditions or different entities? Curr Pharm Des. 2020;26(10):1025–1035. doi:10.2174/1381612826666200131103018
   PubMed Web of Science ®Google Scholar
• Esler WP, Bence KK. Metabolic targets in nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol. 2019;8(2):247–267. doi:10.1016/j.jcmgh.2019.04.007
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang L, Li S, et al. Association of iron storage markers with metabolic syndrome and its components in Chinese rural 6–12 years old children: the 2010–2012 China national nutrition and health survey. Nutrients. 2020;12(5):1486. doi:10.3390/nu12051486
   PubMedGoogle Scholar
• Barbalho SM, Tofano RJ, Bechara MD, Quesada K, Coqueiro DP, Mendes C. Castelli Index and estimative of LDL-c particle size may still help in the clinical practice? J Cardiovasc Dis Res. 2016;7(2):86–89.
   Google Scholar
• Honda H, Ono K, Akizawa T, Nitta K, Hishida A. Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis. Clin Exp Nephrol. 2018;22(3):638–646. doi:10.1007/s10157-017-1501-y
   PubMedGoogle Scholar
• Coimbra S, Catarino C, Nascimento H, et al. Physical exercise intervention at school improved hepcidin, inflammation, and iron metabolism in overweight and obese children and adolescents. Pediatr Res. 2017;82(5):781–788. doi:10.1038/pr.2017.139
   PubMedGoogle Scholar
• Cho MR, Park JK, Choi WJ, Cho AR, Lee YJ. Serum ferritin level is positively associated with insulin resistance and metabolic syndrome in postmenopausal women: a nationwide population-based study. Maturitas. 2017;103:3–7. doi:10.1016/j.maturitas.2017.06.004
   PubMed Web of Science ®Google Scholar
• Kilani N, Waeber G, Vollenweider P, Marques-Vidal P. Markers of iron metabolism and metabolic syndrome in Swiss adults. Nutr Metab Cardiovasc Dis. 2014;24(8):e28–29. doi:10.1016/j.numecd.2014.04.018
   PubMedGoogle Scholar
• Sun L, Franco OH, Hu FB, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab. 2008;93(12):4690–4696. doi:10.1210/jc.2008-1159
   PubMedGoogle Scholar
• Adamska A, Łebkowska A, Krentowska A, Adamski M, Kowalska I. The association between serum ferritin concentration and visceral adiposity estimated by whole-body DXA scan in women with polycystic ovary syndrome. Front Endocrinol. 2019;10:873. doi:10.3389/fendo.2019.00873
   PubMedGoogle Scholar
• Boemeke L, Raimundo FV, Bopp M, Leonhardt LR, Fernandes SA, Marroni CA. The correlation of neck circumference and insulin resistance in nafld patients. Arq Gastroenterol. 2019;56(1):28–33. doi:10.1590/s0004-2803.201900000-06
   PubMedGoogle Scholar
• Choma SS, Alberts M, Modjadji SE. Conflicting effects of BMI and waist circumference on iron status. J Trace Elem Med Biol. 2015;32:73–78. doi:10.1016/j.jtemb.2015.06.003
   PubMedGoogle Scholar
• Shim YS, Kang MJ, Oh YJ, Baek JW, Yang S, Hwang IT. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: the Korean National Health and Nutrition Examination Survey, 2008 to 2011. Medicine. 2017;96(8):e6179. doi:10.1097/MD.0000000000006179
   PubMedGoogle Scholar
• Park SK, Ryoo JH, Kim MG, Shin JY. Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study. Diabetes Care. 2012;35(12):2521–2526. doi:10.2337/dc12-0543
   PubMedGoogle Scholar
• Kim JW, Kim DH, Roh YK, et al. Serum ferritin levels are positively associated with metabolically obese normal weight: a nationwide population-based study. Medicine. 2015;94(52):e2335. doi:10.1097/MD.0000000000002335
   PubMedGoogle Scholar
• Olesnevich ME, Fanelli Kuczmarski M, Mason M, Fang C, Zonderman AB, Evans MK. Serum ferritin levels associated with increased risk for developing CHD in a low-income urban population. Public Health Nutr. 2012;15(7):1291–1298. doi:10.1017/S1368980011003284
   PubMedGoogle Scholar
• Sachinidis A, Doumas M, Imprialos K, Stavropoulos K, Katsimardou A, Athyros VG. Dysmetabolic iron overload in metabolic syndrome. Curr Pharm Des. 2020;26(10):1019–1024. doi:10.2174/1381612826666200130090703
   PubMedGoogle Scholar
• Dragović G, Sumarac-Dumanovic M, Khawla AM, et al. Correlation between PAI-1, leptin and ferritin with HOMA in HIV/AIDS patients. Exp Mol Pathol. 2018;105(1):115–119. doi:10.1016/j.yexmp.2018.06.004
   PubMedGoogle Scholar
• Chen L, Li Y, Zhang F, Zhang S, Zhou X, Ji L. Elevated serum ferritin concentration is associated with incident type 2 diabetes mellitus in a Chinese population: a prospective cohort study. Diabetes Res Clin Pract. 2018;139:155–162. doi:10.1016/j.diabres.2018.03.001
   PubMedGoogle Scholar
• Haap M, Fritsche A, Mensing HJ, Häring HU, Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med. 2003;139(10):869–871. doi:10.7326/0003-4819-139-10-200311180-00029
   PubMed Web of Science ®Google Scholar
• Kim CH, Kim HK, Bae SJ, Park JY, Lee KU. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 2011;60(3):414–420. doi:10.1016/j.metabol.2010.03.007
   PubMed Web of Science ®Google Scholar
• Zhou FL, Gao Y, Tian L, et al. Serum ferritin is associated with carotid atherosclerotic plaques but not intima-media Thickness in patients with abnormal glucose metabolism. Clin Chim Acta. 2015;450:190–195. doi:10.1016/j.cca.2015.08.024
   PubMedGoogle Scholar
• Pitchika A, Schipf S, Nauck M, et al. Associations of iron markers with type 2 diabetes mellitus and metabolic syndrome: results from the prospective SHIP study. Diabetes Res Clin Pract. 2020;163:108149. doi:10.1016/j.diabres.2020.108149
   PubMedGoogle Scholar
• Suárez-Ortegón MF, McLachlan S, Wild SH, Fernández-Real JM, Hayward C, Polašek O. Soluble transferrin receptor levels are positively associated with insulin resistance but not with the metabolic syndrome or its individual components. Br J Nutr. 2016;116(7):1165–1174. doi:10.1017/S0007114516002968
   PubMedGoogle Scholar
• Tang Q, Liu Z, Tang Y, et al. High serum ferritin level is an independent risk factor for metabolic syndrome in a Chinese male cohort population. Diabetol Metab Syndr. 2015;7:11. doi:10.1186/s13098-015-0004-9
   PubMed Web of Science ®Google Scholar
• Hämäläinen P, Saltevo J, Kautiainen H, Mäntyselkä P, Vanhala M. Serum ferritin levels and the development of metabolic syndrome and its components: a 6.5-year follow-up study. Diabetol Metab Syndr. 2014;6(1):114. doi:10.1186/1758-5996-6-114
   PubMedGoogle Scholar
• Deugnier Y, Bardou-Jacquet É, Lainé F. Dysmetabolic iron overload syndrome (DIOS). Presse medicale. 2017;46(12):e306–e311. doi:10.1016/j.lpm.2017.05.036
   PubMedGoogle Scholar
• Moirand R, Mortaji AM, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 1997;349(9045):95–97. doi:10.1016/S0140-6736(96)06034-5
   PubMedGoogle Scholar
• Makker J, Hanif A, Bajantri B, Chilimuri S. Dysmetabolic hyperferritinemia: all iron overload is not hemochromatosis. Case Rep Gastroenterol. 2015;9(1):7–14. doi:10.1159/000373883
   PubMedGoogle Scholar
• Zhang Y, Zhang G, Liang Y, et al. Potential mechanisms underlying the hepatic-protective effects of danshensu on iron overload mice. Biol Pharm Bull. 2020;43(6):968–975. doi:10.1248/bpb.b19-01084
   PubMedGoogle Scholar
• Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19(1):56. doi:10.1186/s12876-019-0972-6
   PubMedGoogle Scholar
• Foisy-Sauvé M, Ahmarani L, Delvin E, Sané AT, Spahis S, Levy E. Glycomacropeptide prevents iron/ascorbate-induced oxidative stress, inflammation and insulin sensitivity with an impact on lipoprotein production in intestinal Caco-2/15 cells. Nutrients. 2020;12(4):1175. doi:10.3390/nu12041175
   PubMedGoogle Scholar
• Protchenko O, Baratz E, Jadhav S, et al. Iron chaperone PCBP1 protects murine liver from lipid peroxidation and steatosis. Hepatology. 2020. doi:10.1002/hep.31328
   PubMedGoogle Scholar
• Shang Y, Luo M, Yao F, Wang S, Yuan Z, Yang Y. Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells. Cell Signal. 2020;72:109633. doi:10.1016/j.cellsig.2020.109633
   PubMed Web of Science ®Google Scholar
• James G, Reisberg S, Lepik K, et al. An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank. PLoS One. 2019;14(4):e0215026. doi:10.1371/journal.pone.0215026
   PubMedGoogle Scholar